Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

One out of the three major indices are trading lower today with the

Dow Jones Industrial Average

(

^DJI

) trading up 11 points (0.1%) at 17,997 as of Friday, Feb. 20, 2015, 12:10 PM ET. The NYSE advances/declines ratio sits at 1,566 issues advancing vs. 1,413 declining with 145 unchanged.

The Health Services industry currently sits down 0.2% versus the S&P 500, which is down 0.1%. Top gainers within the industry include

AMN Healthcare Services

(

AHS

), up 14.3%,

Humana

(

HUM

), up 1.6%,

Agilent Technologies

(

A

), up 1.4%,

Catamaran

(

CTRX

), up 1.1% and

Cigna

(

CI

), up 0.8%. On the negative front, top decliners within the industry include

Grifols

(

GRFS

), down 1.6%,

Baxter International

(

BAX

), down 1.2% and

Boston Scientific

(

BSX

), down 0.7%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3.

Thermo Fisher Scientific

(

TMO

) is one of the companies pushing the Health Services industry higher today. As of noon trading, Thermo Fisher Scientific is up $1.75 (1.4%) to $129.54 on average volume. Thus far, 839,221 shares of Thermo Fisher Scientific exchanged hands as compared to its average daily volume of 1.7 million shares. The stock has ranged in price between $127.15-$129.86 after having opened the day at $127.50 as compared to the previous trading day's close of $127.79.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics in the United States and internationally. Thermo Fisher Scientific has a market cap of $51.2 billion and is part of the health care sector. Shares are up 2.0% year-to-date as of the close of trading on Thursday. Currently there are 13 analysts who rate Thermo Fisher Scientific a buy, no analysts rate it a sell, and none rate it a hold.

TheStreet Ratings rates

Thermo Fisher Scientific

as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth, compelling growth in net income, reasonable valuation levels and good cash flow from operations. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full

Thermo Fisher Scientific Ratings Report

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading,

Abbott Laboratories

(

ABT

) is up $0.27 (0.6%) to $46.88 on average volume. Thus far, 2.4 million shares of Abbott Laboratories exchanged hands as compared to its average daily volume of 5.4 million shares. The stock has ranged in price between $46.40-$46.92 after having opened the day at $46.53 as compared to the previous trading day's close of $46.61.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Abbott Laboratories manufactures and sells health care products worldwide. Abbott Laboratories has a market cap of $69.9 billion and is part of the health care sector. Shares are up 3.5% year-to-date as of the close of trading on Thursday. Currently there are 12 analysts who rate Abbott Laboratories a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates

Abbott Laboratories

as a

buy

. The company's strengths can be seen in multiple areas, such as its increase in net income, solid stock price performance, growth in earnings per share and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full

Abbott Laboratories Ratings Report

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading,

UnitedHealth Group

(

UNH

) is up $0.97 (0.9%) to $111.00 on light volume. Thus far, 1.5 million shares of UnitedHealth Group exchanged hands as compared to its average daily volume of 4.2 million shares. The stock has ranged in price between $109.44-$111.19 after having opened the day at $109.96 as compared to the previous trading day's close of $110.03.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States. UnitedHealth Group has a market cap of $104.7 billion and is part of the health care sector. Shares are up 8.8% year-to-date as of the close of trading on Thursday. Currently there are 15 analysts who rate UnitedHealth Group a buy, 1 analyst rates it a sell, and 3 rate it a hold.

TheStreet Ratings rates

UnitedHealth Group

as a

buy

. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, revenue growth, largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full

UnitedHealth Group Ratings Report

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health services industry could consider

ProShares Ultra Short Health Care

(

RXD

).

null